PATENT CLAIM ANALYSIS

Application Number: 16126193
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-10
Patent Classification: ["424", "661000"]

Abstract:
Disclosed herein are methods and compositions for treating, inhibiting, or ameliorating pulmonary infections, including cystic fibrosis. Aspects described herein relate to compositions including a saline solution and hypochlorite and methods of using these compositions alone or in combination with additional compounds, including antibiotics, an anti-inflammatories, bronchodilators, mucolytics, or oxygen therapy for treating, ameliorating, or inhibiting a pulmonary infection, including cystic fibrosis.

Claim (Index 4):
The method of  claim 1 , wherein the composition is administered intranasally or by inhalation.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.72093
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10838338', '10290443', '11901866', '10682130', '15549073']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7011665548881716
- 35 USC 102 Novelty (BERT): 0.4818940446429067
- Combined Prediction Score: 0.6792393038636451
- Mean Citation Score: 208.100916
- Max Citation Score: 224.36946
- Similarity Product: 199.8814475364661

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test